Mr. Trevor Vieweg reports

MEDBRIGHT AI REACHES US$100M IN TOTAL CLINIC REVENUE UNDER CONTRACT WITH MEDMATRIX, THE AI-POWERED DATA ANALYTICS PLATFORM

Medbright AI Investments Inc. has achieved its near-term goal of total clinic revenue under management with MedMatrix, the artificial-intelligence-powered data analytics platform.

Fourteen clinics in total across the United States and Canada, representing an estimated $100-million (U.S.) in total clinic revenue, are now using MedMatrix.

"The adoption of MedMatrix has been extraordinary, with multiple clinic groups signing on in just two short months," said Dr. Jaime Gerber, chairman of Medbright AI. "We look forward to continued expansion to many more clinic groups and continuing our rapid growth trajectory."

Medbright AI is the primary shareholder in MedMatrix, an AI-powered data analytics platform. MedMatrix harnesses the power of artificial intelligence to evaluate and analyze key aspects of health care facilities, including patient needs and resource matching, revenue cycle management, patient demographics, facility geography, and competition. Through its advanced AI and data analytics capabilities, MedMatrix works alongside health care professionals to optimize each of these critical areas, resulting in more efficient clinic operations and improved patient outcomes.

About Medbright AI Investments Inc.

Medbright AI is a capital allocator focused on investing in health care technology companies. The team at Medbright prides itself on unparalleled access to opportunities, as well as structuring unique and advantageous investments. Medbright's mission is to construct a portfolio of synergistic investments to generate superior returns for shareholders. Medbright will focus on significant near-term and midterm high-quality opportunities with strong return potentials while maintaining commitment to governance.

We seek Safe Harbor.